The aim was to evaluate the usefulness of serum ACE, serum lysozyme and polyclonal antibody activation and compare the frequency of increased serum levels of lysozyme and ACE and their sensitivities and specificities in proven ocular sarcoidosis or in suspected ocular sarcoidosis cases. This evidence concerns the gene LYZ and ocular sarcoidosis.